CRYAB and myeloid sarcoma: In conclusion, this study supports the role of CRYAB as an autoantigen in MS and demonstrates that CRYAB autoreactivity is cross-reactive with EBNA1 due to molecular mimicry, likely a result of EBV-targeted immunity.